Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 33 Colorectal Neoplasms 13 Neoplasms 11 Pain, Postoperative 10 Lung Neoplasms 9 Brain Neoplasms 8 Stomach Neoplasms 7 Prostatic Neoplasms 7 Pancreatic Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Melanoma 6 Leukemia, Myeloid, Acute 5 Ovarian Neoplasms 4 Myoma 4 Lymphoma, Non-Hodgkin 4 Leiomyoma 4 Hemorrhage 4 Head and Neck Neoplasms 4 Glioblastoma 4 Colonic Neoplasms 4 Agnosia 4 Skin Neoplasms 3 Recurrence 3 Rectal Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neurotoxicity Syndromes 3 Neoplasm Metastasis 3 Nasopharyngeal Carcinoma 3 Myelodysplastic Syndromes 3 Multiple Endocrine Neoplasia Type 1 3

Interventions

Carboplatin 15 Pemetrexed 8 Paclitaxel 6 pembrolizumab 5 osimertinib 4 atezolizumab 4 Gemcitabine 4 Erlotinib Hydrochloride 4 entinostat 3 durvalumab 3 Cisplatin 3 selpercatinib 2 pralsetinib 2 camrelizumab 2 apatinib 2 Vinorelbine 2 Radiosurgery 2 Nivolumab 2 Injections 2 Gefitinib 2 Bevacizumab 2 130-nm albumin-bound paclitaxel 2 toripalimab 1 sotorasib 1 sintilimab 1 repotrectinib 1 pegylated granulocyte colony-stimulating factor 1 patritumab 1 necitumumab 1 napabucasin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Thoracic Neoplasms × Sodium Chloride × Clear all

NCT04209868 2024-03-29

ParaSOL

Guy's and St Thomas' NHS Foundation Trust

Phase 2/3 Unknown

Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡